ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer.
Small W, Jr., Hayes JP, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Jones WE, 3rd, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, and Herman JM. Acr appropriateness criteria(r) borderline and unresectable pancreas cancer. Oncology (Williston Park) 2016; 30(7):619-624, 627, 632.
Oncology (Williston Park)
The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel reviewed the pertinent literature and voted on five variants to establish appropriate recommended treatment of borderline and unresectable pancreatic cancer. The guidelines reviewed the use of radiation, chemotherapy, and surgery. Radiation technique, dose, and targets were evaluated, as was the recommended chemotherapy, administered either alone or concurrently with radiation. This report will aid clinicians in determining guidelines for the optimal treatment of borderline and unresectable pancreatic cancer.
Medical Subject Headings
Chemoradiotherapy; Consensus; Guidelines as Topic; Humans; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Radiology; Treatment Outcome; United States